Targeting blockage of STAT3 inhibits hepatitis B virus-related hepatocellular carcinoma

References

• Center MM, Jemal A. International trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers Prev 2011; 20:2362-8; PMID: 21921256; http://dx.doi.org/10.1158/1055-9965.EPI-11-0643
   PubMed Web of Science ®Google Scholar
• Barazani Y, Hiatt JR, Tong MJ, Busuttil RW. Chronic viral hepatitis and hepatocellular carcinoma. World J Surg 2007; 31:1243-8; PMID:17440771; http://dx.doi.org/10.1007/s00268-007-9041-3
   PubMed Web of Science ®Google Scholar
• El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142:1264-73.e1; PMID:22537432; http://dx.doi.org/10.1053/j.gastro.2011.12.061
   PubMed Web of Science ®Google Scholar
• Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, Paterlini-Brechot P, Brechot C, Kremsdorf D. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res 2001; 61:7803-10; PMID:11691796
   PubMed Web of Science ®Google Scholar
• Jiang Z, Jhunjhunwala S, Liu J, Haverty PM, Kennemer MI, Guan Y, Lee W, Carnevali P, Stinson J, Johnson S, et al. The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. Genome Res 2012; 22:593-601; PMID:22267523; http://dx.doi.org/10.1101/gr.133926.111
   PubMed Web of Science ®Google Scholar
• Benhenda S, Cougot D, Buendia MA, Neuveut C. Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis. Adv Cancer Res 2009; 103:75-109; PMID:19854353; http://dx.doi.org/10.1016/S0065-230X(09)03004-8
   PubMed Web of Science ®Google Scholar
• Dewantoro O, Gani RA, Akbar N. Hepatocarcinogenesis in viral Hepatitis B infection: the role of HBx and p53. Acta Med Indones 2006; 38:154-9; PMID:16953033
   PubMedGoogle Scholar
• Lucito R, Schneider RJ. Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C. J Virol 1992; 66:983-91; PMID:1309924
   PubMed Web of Science ®Google Scholar
• Lee YH, Yun Y. HBx protein of hepatitis B virus activates Jak1-STAT signaling. J Biol Chem 1998; 273:25510-5; PMID:9738022; http://dx.doi.org/10.1074/jbc.273.39.25510
   PubMed Web of Science ®Google Scholar
• Hodge DR, Hurt EM, Farrar WL. The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 2005; 41:2502-12; PMID:16199153; http://dx.doi.org/10.1016/j.ejca.2005.08.016
   PubMed Web of Science ®Google Scholar
• Waris G, Siddiqui A. Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function. J Virol 2002; 76:2721-9; PMID:11861839; http://dx.doi.org/10.1128/JVI.76.6.2721-2729.2002
   PubMed Web of Science ®Google Scholar
• Munoz J, Dhillon N, Janku F, Watowich SS, Hong DS. STAT3 inhibitors: finding a home in lymphoma and leukemia. Oncologist 2014; 19:536-44; PMID:24705981; http://dx.doi.org/10.1634/theoncologist.2013-0407
   PubMed Web of Science ®Google Scholar
• Sun X, Zhang J, Wang L, Tian Z. Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN. Cancer Lett 2008; 262:201-13; PMID:18248786; http://dx.doi.org/10.1016/j.canlet.2007.12.009
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang J, Wei H, Tian Z. STAT3-decoy oligodeoxynucleotide inhibits the growth of human lung cancer via down-regulating its target genes. Oncol Rep 2007; 17:1377-82; PMID:17487394; http://dx.doi.org/10.3892/or.17.6.1377
   PubMed Web of Science ®Google Scholar
• Yang P, Markowitz GJ, Wang XF. The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma. Natl Sci Rev 2014; 1:396-412; PMID:25741453; http://dx.doi.org/10.1093/nsr/nwu038
   PubMed Web of Science ®Google Scholar
• Yen CJ, Lin YJ, Yen CS, Tsai HW, Tsai TF, Chang KY, Huang WC, Lin PW, Chiang CW, Chang TT. Hepatitis B virus X protein upregulates mTOR signaling through IKKbeta to increase cell proliferation and VEGF production in hepatocellular carcinoma. PloS One 2012; 7:e41931; PMID:22848663; http://dx.doi.org/10.1371/journal.pone.0041931
   PubMedGoogle Scholar
• Ayub A, Ashfaq UA, Haque A. HBV induced HCC: major risk factors from genetic to molecular level. BioMed Res Int 2013; 2013:810461; PMID:23991421; http://dx.doi.org/10.1155/2013/810461
   PubMed Web of Science ®Google Scholar
• Tan ZM, Sun BC. Effects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence. World J Gastroenterol 2013; 19:8895-901; PMID:24379613; http://dx.doi.org/10.3748/wjg.v19.i47.8895
   PubMed Web of Science ®Google Scholar
• Kim DJ, Chan KS, Sano S, Digiovanni J. Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesis. Mol Carcinogen 2007; 46:725-31; PMID:17610223; http://dx.doi.org/10.1002/mc.20342
   PubMed Web of Science ®Google Scholar
• Li N, Grivennikov SI, Karin M. The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment. Cancer Cell 2011; 19:429-31; PMID:21481782; http://dx.doi.org/10.1016/j.ccr.2011.03.018
   PubMed Web of Science ®Google Scholar
• Quetier I, Brezillon N, Duriez M, Massinet H, Giang E, Ahodantin J, Lamant C, Brunelle MN, Soussan P, Kremsdorf D. Hepatitis B virus HBx protein impairs liver regeneration through enhanced expression of IL-6 in transgenic mice. J Hepatol 2013; 59:285-91; PMID:23542345; http://dx.doi.org/10.1016/j.jhep.2013.03.021
   PubMed Web of Science ®Google Scholar
• Yu H, Kortylewski M, Pardoll D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 2007; 7:41-51; PMID:17186030; http://dx.doi.org/10.1038/nri1995
   PubMed Web of Science ®Google Scholar
• Sun X, Sui Q, Zhang C, Tian Z, Zhang J. Targeting blockage of STAT3 in hepatocellular carcinoma cells augments NK cell functions via reverse hepatocellular carcinoma-induced immune suppression. Mol Cancer Ther 2013; 12:2885-96; PMID:24107450; http://dx.doi.org/10.1158/1535-7163.MCT-12-1087
   PubMed Web of Science ®Google Scholar
• Koda M, Nagahara T, Matono T, Sugihara T, Mandai M, Ueki M, Ohyama K, Hosho K, Okano J, Kishimoto Y, et al. Nucleotide analogs for patients with HBV-related hepatocellular carcinoma increase the survival rate through improved liver function. Inter Med 2009; 48:11-7; PMID:19122351; http://dx.doi.org/10.2169/internalmedicine.48.1534
   PubMed Web of Science ®Google Scholar
• Ke Y, Ma L, You XM, Huang SX, Liang YR, Xiang BD, Li LQ, Zhong JH. Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy. Cancer Biol Med 2013; 10:158-64; PMID:24379991; http://dx,doi.org/10.7497/j.issn.2095-3941.2013.03.006
   PubMedGoogle Scholar
• Dienstag JL. Hepatitis B virus infection. N Engl J Med 2008; 359:1486-500; PMID:18832247; http://dx.doi.org/10.1056/NEJMra0801644
   PubMed Web of Science ®Google Scholar
• Dusheiko G. Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues. Liver Int 2013; 33(Suppl 1):137-50; PMID:23286858; http://dx.doi.org/10.1111/liv.12078
   PubMed Web of Science ®Google Scholar
• Uprichard SL. The therapeutic potential of RNA interference. FEBS Lett 2005; 579:5996-6007; PMID:16115631; http://dx.doi.org/10.1016/j.febslet.2005.08.004
   PubMed Web of Science ®Google Scholar
• Dickins RA, Hemann MT, Zilfou JT, Simpson DR, Ibarra I, Hannon GJ, Lowe SW. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat Genet 2005; 37:1289-95; PMID:16200064; http://dx,doi.org/10.1038/ng1651
   PubMed Web of Science ®Google Scholar
• Ohguchi S, Nakatsukasa H, Higashi T, Ashida K, Nouso K, Ishizaki M, Hino N, Kobayashi Y, Uematsu S, Tsuji T. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy. Hepatology 1998; 27:599-607; PMID:9462663; http://dx.doi.org/10.1002/hep.510270239
   PubMed Web of Science ®Google Scholar
• Nguyen TH, Pages JC, Farge D, Briand P, Weber A. Amphotropic retroviral vectors displaying hepatocyte growth factor-envelope fusion proteins improve transduction efficiency of primary hepatocytes. Hum Gene Ther 1998; 9:2469-79; PMID:9853514; http://dx.doi.org/10.1089/hum.1998.9.17-2469
   PubMed Web of Science ®Google Scholar
• Nguyen TH, Loux N, Dagher I, Vons C, Carey K, Briand P, Hadchouel M, Franco D, Jouanneau J, Schwall R, et al. Improved gene transfer selectivity to hepatocarcinoma cells by retrovirus vector displaying single-chain variable fragment antibody against c-Met. Cancer Gene Ther 2003; 10:840-9; PMID:14605670; http://dx.doi.org/10.1038/sj.cgt.7700640
   PubMed Web of Science ®Google Scholar
• Whittaker S, Marais R, Zhu AX. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 2010; 29:4989-5005; PMID:20639898; http://dx.doi.org/10.1038/onc.2010.236
   PubMed Web of Science ®Google Scholar
• Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A 1987; 84:1005-9; PMID:3029758; http://dx.doi.org/10.1073/pnas.84.4.1005
   PubMed Web of Science ®Google Scholar
• Huang LR, Wu HL, Chen PJ, Chen DS. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc Natl Acad Sci U S A 2006; 103:17862-7; PMID:17095599; http://dx.doi.org/10.1073/pnas.0608578103
   PubMed Web of Science ®Google Scholar
• Huang C, Yang G, Jiang T, Cao J, Huang KJ, Qiu ZJ. Down-regulation of STAT3 expression by vector-based small interfering RNA inhibits pancreatic cancer growth. World J Gastroenterol 2011; 17:2992-3001; PMID: 21799645; http://dx.doi.org/10.3748/wjg.v17.i25.2992
   PubMed Web of Science ®Google Scholar
• Salani D, Taraboletti G, Rosano L, Di Castro V, Borsotti P, Giavazzi R, Bagnato A. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol 2000; 157:1703-11; PMID:11073829; http://dx.doi.org/10.1016/S0002-9440(10)64807-9
   PubMed Web of Science ®Google Scholar